Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ATORVASTATIN for Obesity: Side Effects & Safety Data

Lose Weight Fast — The 21-Day Smoothie Diet

36 fat-burning recipes + shopping lists. Results in the first week.

Get the Program

There are 26 adverse event reports in the FDA FAERS database where ATORVASTATIN was used for Obesity.

Most Reported Side Effects for ATORVASTATIN

Side Effect Reports % Deaths Hosp.
Type 2 diabetes mellitus 7,556 9.5% 84 166
Myalgia 7,155 9.0% 233 1,230
Drug hypersensitivity 3,929 4.9% 8 147
Drug ineffective 3,865 4.9% 80 1,134
Fatigue 3,439 4.3% 237 1,096
Arthralgia 3,338 4.2% 239 642
Rhabdomyolysis 3,286 4.1% 330 2,298
Dyspnoea 3,137 3.9% 313 1,516
Nausea 2,888 3.6% 237 1,298
Asthenia 2,791 3.5% 291 1,200
Headache 2,747 3.5% 228 940
Pain 2,700 3.4% 20 1,000
Malaise 2,614 3.3% 222 1,261
Muscle spasms 2,581 3.3% 12 408
Pain in extremity 2,522 3.2% 23 637

Other Indications for ATORVASTATIN

Product used for unknown indication (22,764) Blood cholesterol increased (10,139) Hypercholesterolaemia (5,615) Dyslipidaemia (4,796) Cardiovascular event prophylaxis (4,792) Low density lipoprotein increased (4,713) Hyperlipidaemia (3,648) Blood cholesterol abnormal (2,024) Blood cholesterol (1,722) Blood triglycerides increased (1,638)

Other Drugs Used for Obesity

SEMAGLUTIDE (2,586) LIRAGLUTIDE (1,090) BUPROPION\NALTREXONE (726) TIRZEPATIDE (700) ORLISTAT (163) PHENTERMINE (127) DULAGLUTIDE (109) METFORMIN (100) PHENTERMINE\TOPIRAMATE (86) TOPIRAMATE (86)

Related Pages

ATORVASTATIN Full Profile All Obesity Drugs ATORVASTATIN Demographics ATORVASTATIN Timeline